Friday, July 10, 2026

pharma · Osteoarthritis of the Knee

CellSeed Europe

CellSeed Europe clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

GB HQ
EMA registrant Type
Company details
Status
Public
HQ
GB
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

CellSeed Europe projects

1 ClinicalTrials.gov programs sponsored by CellSeed Europe.

CellSeed Europe has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. CLS2901C (human [allogeneic] chondrocyte sheets)

    CellSeed Europe Ltd

    Osteoarthritis of the Knee

    phase 3 mab active

    1 trial

Frequently asked questions

How many clinical projects does CellSeed Europe have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.